Комментарий к статье «Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation»

В связи с публикацией статьи «Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation» нами выпущен комментарий. Авторы посвятили свою статью широко обсуждаемой теме «Короткие эпизоды быстрых аритмий, первоначально выявляемых в записях на имплантируемых устройствах». В дальнейшем эти эпизоды исследуются уже при Холтеровском мониторировании разной длительности и оценивается их клиническое значение. Этому посвящена цитируемая статья и наш комментарий.

1. Toennis T, Bertaglia E, Brandes A, Dichtl W, Fluschnik N, De Groot JR et al. The influence of atrial high-rate episodes on stroke and cardiovascular death: an update. Europace. 2023;25(7):euad166. DOI: 10.1093/europace/euad166

2. Khan AA, Boriani G, Lip GYH. Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? Clinical Research in Cardiology. 2020;109(4):409–16. DOI: 10.1007/s00392-019-01545-4

3. Аракелян М.Г., Бокерия Л.А., Васильева Е.Ю., Голицын С.П., Голухова Е.З., Горев М.В. и др. Фибрилляция и трепетание предсердий. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(7):190-260. DOI: 10.15829/1560-4071-2021-4594

4. Boriani G, Vitolo M, Imberti JF, Potpara TS, Lip GYH. What do we do about atrial high rate episodes? European Heart Journal Supplements. 2020;22(Suppl O):O42–52. DOI: 10.1093/eurheartj/suaa179

5. Gherasim L. Subclinical Atrial Fibrillation, Embolic Risk, and Anticoagulant Treatment. MAEDICA – a Journal of Clinical Medicine. 2018;13(4):261–5. DOI: 10.26574/maedica.2018.13.4.261

6. Noseworthy PA, Kaufman ES, Chen LY, Chung MK, Elkind MSV, Joglar JA et al. Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. Circulation. 2019;140(25):e944–63. DOI: 10.1161/CIR.0000000000000740

7. Imberti JF, Bonini N, Tosetti A, Mei DA, Gerra L, Malavasi VL et al. Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation. Biology. 2022;11(3):443. DOI: 10.3390/biology11030443

8. Disertori M, Franzosi MG, Barlera S, Cosmi F, Quintarelli S, Favero C et al. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial. BMC Cardiovascular Disorders. 2013;13(1):28. DOI: 10.1186/1471-2261-13-28

9. Kottkamp H. Fibrotic Atrial Cardiomyopathy: A Specific Disease/Syndrome Supplying Substrates for Atrial Fibrillation, Atrial Tachycardia, Sinus Node Disease, AV Node Disease, and Thromboembolic Complications. Journal of Cardiovascular Electrophysiology. 2012;23(7):797–9. DOI: 10.1111/j.1540-8167.2012.02341.x

10. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation. Circulation. 1997;96(4):1180–4. DOI: 10.1161/01.CIR.96.4.1180

11. Kułach A, Dewerenda M, Majewski M, Lasek-Bal A, Gąsior Z. 72 hour Holter monitoring, 7 day Holter monitoring, and 30 day intermittent patient-activated heart rhythm recording in detecting arrhythmias in cryptogenic stroke patients free from arrhythmia in a screening 24 h Holter. Open Medicine. 2020;15(1):697–701. DOI: 10.1515/med-2020-0203

12. Van Gelder IC, Healey JS, Crijns HJGM, Wang J, Hohnloser SH, Gold MR et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. European Heart Journal. 2017;38(17):1339–44. DOI: 10.1093/eurheartj/ehx042

13. Kreimer F, Mügge A, Gotzmann M. How should I treat patients with subclinical atrial fibrillation and atrial high-rate episodes? Current evidence and clinical importance. Clinical Research in Cardiology. 2022;111(9):994–1009. DOI: 10.1007/s00392-022-02000-7

14. Becher N, Toennis T, Bertaglia E, Blomström-Lundqvist C, Brandes A, Cabanelas N et al. Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h. European Heart Journal. 2024;45(10):837–49. DOI: 10.1093/eurheartj/ehad771

15. Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N et al. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. New England Journal of Medicine. 2023;389(13):1167–79. DOI: 10.1056/NEJMoa2303062

16. Potpara T, Blomstrom-Lundqvist C. Anticoagulation in patients with atrial high-rate episodes. Nature Reviews Cardiology. 2024;21(1):5–6. DOI: 10.1038/s41569-023-00963-2